Active	Status	Sponsor type	Region	Phase	Filter
7 Active 2 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Yagi, Michio
NCT05486208: A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis	Terminated	1	102	Japan, US	LY3844583, Placebo	Eli Lilly and Company	Healthy, Dermatitis, Atopic	01/24	01/24
NCT06119529: A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis	Recruiting	1	179	Japan, US	LY3872386, Prednisone, Placebo	Eli Lilly and Company	Healthy, Atopic Dermatitis	01/26	01/26
Parish, Jennifer L
NCT05310734: PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies	Recruiting	4	50	US	Spinosad Topical, Natroba, benzyl alcohol	ParaPRO LLC, Concentrics Research, Iqvia Pty Ltd, Medpace, Inc., Inotiv Laboratories, BioAgilytix	Scabies	11/25	03/26
NCT04877756: Study to Evaluate Efficacy of OLX10010 in Reducing Recurrence of Hypertrophic Scarring After Scar Revision Surgery	Completed	2	22	US	OLX10010, a cell penetrating asymmetric small interference RNA (cp-asiRNA), targeting a gene involved in formation of fibrosis	Olix Pharmaceuticals, Inc., Alira Health	Hypertrophic Scar	01/23	07/23
NCT05875441: Efficacy and Safety Study of Moxidectin in Adults With Scabies	Recruiting	2	200	US, RoW	Moxidectin Oral Product, Placebo	Medicines Development for Global Health	Scabies	09/24	12/24
RECAST DLE, NCT05591222 / 2022-000831-21: Study of Daxdilimab (HZN-7734) in Patients With Moderate-to-Severe Primary Discoid Lupus Erythematosus	Recruiting	2	99	Europe, Canada, US, RoW	Placebo/Daxdilimab, Daxdilimab, HZN-7734	Amgen, Horizon Therapeutics Ireland DAC	Discoid Lupus Erythematosus	07/24	12/24
NCT06119529: A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis	Recruiting	1	179	Japan, US	LY3872386, Prednisone, Placebo	Eli Lilly and Company	Healthy, Atopic Dermatitis	01/26	01/26
Owada, Yasuko
No trials found